TRI: Past, Present and Future
Hear more about how TRI started and what it does today.
Latest Tweets
Looking to change jobs in 2022? We’re recruiting!
Come and work with a leader in the field of thrombosis research
You could:
- work on studies involving large databases and wearables, or
- analyse RCTs and registry data, or
- pioneer cutting edge research
https://t.co/IkVukJWXV4
The first edition of In-CYTE is live.
This issue includes an interview with Professor John Camm, a look at the CYTE and Syneos partnership, insight on CYTE’s formation, and much more!
Access it here: https://t.co/zPNisPm2ga
A 70-year-old man with moderate renal impairment (creatinine clearance = 30-49 ml/min), who was treated with rivaroxaban for atrial fibrillation (AF), falls and needs urgent hip surgery. His last dose of rivaroxaban was 2 hours before admission. Let’s work on his treatment plan.
The RIVER study ran here at TRI officially ended in 2020, but important insights are still being gleaned. Click here to read a RIVER abstract that was accepted at this year's ESC:
Rivaroxaban dosing in patients with atrial fibrillation: results from the RIVER registry – is dosing according to renal function appropriate?
AbstractIntroduction. Rivaroxaban is recommended as an option for anticoagulation in patients with nonvalvular atrial fibrillation (AF) with one or mo...
academic.oup.com
Find out about the clinical insights gathered from the RIVER study here:
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER) - Thrombosis Journal
Background Real-world data on non-vitamin K oral anticoagulants (NOACs) are essential in determining whether evidence from randomised controlled clini...
thrombosisjournal.biomedcentral.com
New technology could help determine COVID-19 patients...
Click to view the article
Article source: News Medical
Venous thromboembolism in Asia and worldwide: Emerging...
Click to view the article
Article source: PubMed
Our work continues: May COVID-19 update from...
GARFIELD-AF Risk Calculator launched on Calculate by...
World Thrombosis Day – 5 Years On
Click to view the article
Article source: The Lancet
Scientists identify biomarkers to predict risk of...
Click to view the article
Article source: News Medical
Alcohol abstinence reduces arrhythmia recurrences, BP in...
Click to view the article
Article source: Healio (Cardiology Today)
Interfacility transfer may increase risk of venous...
Click to view the article
Article source: Healio